{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-26-000023","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.953330+00:00","generated_at":"2026-05-14T23:49:29.582096+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Edwards Lifesciences appoints Theodora Mistras as CFO, effective May 29, 2026","bullets":["Theodora Mistras appointed CFO effective May 29, 2026, succeeding Scott Ullem (announced October transition).","Compensation: $925K base salary, $2.013M sign-on bonus (pro-rata clawback within 24 months), $8M RSUs (vesting over 3 years).","Mistras was previously CFO of Viatris (since March 2024) and held senior roles at Citigroup and Goldman Sachs in healthcare IB.","She is eligible for severance of at least 1x base salary plus 1x target bonus, pro-rated bonus, and $50K outplacement."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-26-000023","json":"https://secwatch.observer/filing/0001099800-26-000023.json","markdown":"https://secwatch.observer/filing/0001099800-26-000023.md","text":"https://secwatch.observer/filing/0001099800-26-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000023/0001099800-26-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000023/ew-20260502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:49:29.582096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eafd305157","claim":"Theodora Mistras was appointed as Corporate Vice President, Chief Financial Officer at Edwards Lifesciences Corp.","evidence_excerpt":"On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B. Ullem in that position.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000023/0001099800-26-000023-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Corporate Vice President, Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}